Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma

British Journal of Cancer

Volumn 111, Issue 5, 2014, Pages 944-954

  Liu, J L ^a,b   Chen, F F ^c   Lung, J ^c   Lo, C H ^a   Lee, F H ^a   Lu, Y C ^a   Hung, C H ^b  

^a ST MARTIN DE PORRES HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

autophagy; immunohistochemistry; in situ hybridization; LC3; oral; p62 SQSTM1; squamous cell carcinoma

Indexed keywords

LC3B PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN P62; SQSTM1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; VERRUCOUS HYPERPLASIA;

ADULT; AUTOPHAGY; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; FEMALE; HUMANS; HYPERPLASIA; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84906938119     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.355     Document Type: Article

References (39)

1. Brech A, Ahlquist T, Lothe RA, Stenmark H (2009) Autophagy in tumour suppression and promotion. Mol Oncol 3(4): 366-375.
2. Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, Braud AC, Puig B, Geneix J, Hassoun J, Birnbaum D (2004) Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'. J Pathol 202(3): 265-273.
3. Choi J, Jung W, Koo JS (2013) Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Histopathology 62(2): 275-286.
4. Giatromanolaki A, Koukourakis MI, Koutsopoulos A, Chloropoulou P, Liberis V, Sivridis E (2011a) High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas. Gynecol Oncol 123(1): 147-151.
5. Giatromanolaki AN, Charitoudis GS, Bechrakis NE, Kozobolis VP, Koukourakis MI, Foerster MH, Sivridis EL (2011b) Autophagy patterns and prognosis in uveal melanomas. Mod Pathol 24(8): 1036-1045.
6. He H, Dang Y, Dai F, Guo Z, Wu J, She X, Pei Y, Chen Y, Ling W, Wu C (2003) Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem 278(31): 29278-29287.
7. Huang JJ, Li HR, Huang Y, Jiang WQ, Xu RH, Huang HQ, Lv Y, Xia ZJ, Zhu XF, Lin TY, Li ZM (2010) Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Autophagy 6(6): 777-783.
8. Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S, Watanabe M, Sakurada A, Endo C, Uruno A, Sasano H, Nakagawa T, Satoh K, Tanaka N, Kubo H, Motohashi H, Yamamoto M (2012) Accumulation of p62/ SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci 103(4): 760-766.
9. Inui T, Chano T, Takikita-Suzuki M, Nishikawa M, Yamamoto G, Okabe H (2013) Association of p62/SQSTM1 excess and oral carcinogenesis. PLoS One 8(9): e74398.
10. Jain A, Lamark T, Sjøttem E, Larsen KB, Awuh JA, Øvervatn A, McMahon M, Hayes JD, Johansen T (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285(29): 22576-22591.
11. Kapoor V, Paliwal D, Baskar Singh S, Mohanti BK, Das SN (2012) Deregulation of Beclin 1 in patients with tobacco-related oral squamous cell carcinoma. Biochem Biophys Res Commun 422(4): 764-769.
12. Kitamura H, Torigoe T, Asanuma H, Hisasue SI, Suzuki K, Tsukamoto T, Satoh M, Sato N (2006) Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue. Histopathology 48(2): 157-161.
13. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7): 844-847.
14. Koukourakis MI, Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC, Harris AL (2010) Beclin 1 over-and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer 103(8): 1209-1214.
15. Kundu M, Thompson CB (2008) Autophagy: basic principles and relevance to disease. Annu Rev Pathol 3: 427-455.
16. Ladoire S, Chaba K, Martins I, Sukkurwala AQ, Adjemian S, Michaud M, Poirier-Colame V, Andreiuolo F, Galluzzi L, White E, Rosenfeldt M, Ryan KM, Zitvogel L, Kroemer G (2012) Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy 8(8): 1175-1184.
17. Levine B (2007) Cell biology: autophagy and cancer. Nature 446(7137): 745-747.
18. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1): 27-42.
19. Ling J, Ya Kang, Zhao R, Xia Q, Lee D-F, Chang Z, Li J, Peng B, Fleming JB, Wang H (2012) KrasG12D-induced IKK2/b/NF-kB activation by IL-1a and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 21(1): 105-120.
20. Luo RZ, Yuan ZY, Li M, Xi SY, Fu J, He J (2013) Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer. OncoTargets Ther 6: 883-888.
21. Martinet W, Schrijvers DM, Timmermans JP, Bult H, De Meyer GR (2013) Immunohistochemical analysis of macroautophagy: recommendations and limitations. Autophagy 9(3): 386-402.
22. Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22): 2861-2873.
23. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451(7182): 1069-1075.
24. Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140(3): 313-326.
25. Nicotra G, Mercalli F, Peracchio C, Castino R, Follo C, Valente G, Isidoro C (2010) Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol 23(7): 937-950.
26. Pankiv S, Lamark T, Bruun JA, Overvatn A, Bjorkoy G, Johansen T (2010) Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J Biol Chem 285(8): 5941-5953.
27. Puissant A, Fenouille N, Auberger P (2012) When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res 2(4): 397.
28. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, Levine B (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112(12): 1809-1820.
29. Ren F, Shu G, Liu G, Liu D, Zhou J, Yuan L, Zhou J (2014) Knockdown of p62/sequestosome 1 attenuates autophagy and inhibits colorectal cancer cell growth. Mol Cell Biochem 385(1-2): 95-102.
30. Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a doubleedged sword. Science 306(5698): 990-995.
31. Sivridis E, Koukourakis MI, Zois CE, Ledaki I, Ferguson DJ,HarrisAL, Gatter KC, Giatromanolaki A (2010) LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol 176(5): 2477-2489.
32. Spowart JE, Townsend KN, Huwait H, Eshragh S, West NR, Ries JN, Kalloger S, Anglesio M, Gorski SM, Watson PH, Gilks CB, Huntsman DG, Lum JJ (2012) The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol 228: 437-447.
33. Tang JY, Hsi E, Huang YC, Hsu NC, Chu PY, Chai CY (2013) High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma. Hum Pathol 44(11): 2558-2562.
34. Wan XB, Fan XJ, Chen MY, Xiang J, Huang PY, Guo L, Wu XY, Xu J, Long ZJ, Zhao Y (2010) Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy 6(3): 395-404.
35. Wang Y, Wang C, Tang H, Wang M, Weng J, Liu X, Zhang R, Huang H, Hou J (2013) Decrease of autophagy activity promotes malignant progression of tongue squamous cell carcinoma. J Oral Pathol Med 42(7): 557-564.
36. Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4-5): 309-316.
37. Won KY, Kim GY, Lim SJ, Kim YW (2012) Decreased Beclin-1 expression is correlated with the growth of the primary tumor in patients with squamous cell carcinoma and adenocarcinoma of the lung. Hum Pathol 43(1): 62-68.
38. Yue Z, Jin S, Yang C, Levine AJ, Heintz N (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100(25): 15077-15082.
39. Zois CE, Giatromanolaki A, Sivridis E, Papaiakovou M, Kainulainen H, Koukourakis MI (2011) "Autophagic flux" in normal mouse tissues: focus on endogenous LC3A processing. Autophagy 7(11): 1371-1378.